Glimin M 4mg/1000mg Tablet SR
By Glimin M
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(4mg) + Metformin(1000mg)

Manufacturer - Divine Lifecare Pvt Ltd
DIVINE LIFE CARE PVT LTD, 220, MAHAGUJARAT IND. ESTATE AT, PO : MORAIYA, TA : SANAND DIST : AHMEDABAD

Expires on or after
March, 2026

liver
When it comes to liver health, caution is advised when using Glimin M 4mg/1000mg Tablet SR. Patients with liver disease should be careful, as dose adjustment may be necessary. It is important to consult your doctor before starting this medication. Typically, Glimin M 4mg/1000mg Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not advisable for those with severe liver disease to use this medication without proper medical guidance. Keeping your doctor informed and seeking their advice is crucial to ensure the safe use of Glimin M 4mg/1000mg Tablet SR.

kidney
Glimin M 4mg/1000mg Tablet SR needs caution for individuals with kidney issues. Dosage adjustment and doctor consultation may be necessary. Avoid for severe kidney disease and monitor kidney function regularly while using this medicine.

alcohol
It is not safe to drink alcohol while taking Glimin M 4mg/1000mg Tablet SR. Avoid alcohol consumption. If unsure, consult your doctor.

driving
Your driving may be impacted by low or high blood sugar levels. Avoid driving if experiencing these symptoms while taking Glimin M 4mg/1000mg Tablet SR.

pregnancy
Glimin M 4mg/1000mg Tablet SR should be used with caution during pregnancy, as it may potentially harm the developing baby based on animal studies. Consult your doctor for consideration of risks and benefits before use.

breastfeeding
Caution should be taken while breastfeeding as Glimin M 4mg/1000mg Tablet SR is unsafe and may cause toxicity to the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹85.5
₹95
10% OFF
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024
